Skip to Main content Skip to Navigation
Theses

Rôle de la VE-statine (EGFL7) dans la tumorigenèse : répression de l'activation des cellules endothéliales et contribution à l'échappement à l'immunité anti-tumorale

Abstract : Angiogenesis, which corresponds to the growth of new blood vessels from pre-existing vessels; is necessary for tumor growth and is an attractive target for anticancer therapy. Since 2004, several antiangiogenic therapies against colon, lung, breast, kidney cancers have been developed and used in clinic.VE-statin/egfl7 was discovered by our team in 2003. It is specifically expressed by endothelial cells during embryonic development and vascular remodelling. Several publications have described the role of VE-statin in vessel formation. VE-statin expression by human tumors has been recently associated with a higher grade and metastatic score and with a poorer prognosis in hepatocellular carcinoma, glioma and colorectal cancer.The aim of my work was to develop tools for the study of the functions of VE-statin in tumor growth and angiogenesis. This analysis allows a better understanding of the mechanisms which modulate tumor progression.
Document type :
Theses
Complete list of metadatas

https://tel.archives-ouvertes.fr/tel-00693157
Contributor : Abes Star :  Contact
Submitted on : Wednesday, May 2, 2012 - 1:09:09 AM
Last modification on : Tuesday, October 27, 2020 - 3:26:06 PM
Long-term archiving on: : Friday, August 3, 2012 - 2:35:09 AM

File

Delfortrie-Suzanne.pdf
Version validated by the jury (STAR)

Identifiers

  • HAL Id : tel-00693157, version 1

Collections

Citation

Suzanne Delfortrie. Rôle de la VE-statine (EGFL7) dans la tumorigenèse : répression de l'activation des cellules endothéliales et contribution à l'échappement à l'immunité anti-tumorale. Médecine humaine et pathologie. Université du Droit et de la Santé - Lille II, 2011. Français. ⟨NNT : 2011LIL2S017⟩. ⟨tel-00693157⟩

Share

Metrics

Record views

817

Files downloads

1368